B Braun Launches New Deep Access IV Catheter for Safer Vascular Access

B. Barun Medical Inc. announced the launch of the Introcan Safety 2 Deep Access Iv Catheter on October 1, 2026, expanding its ultrasound-guided deep access portfolio. The new peripheral intravenous catheter is designed for patients with difficult venous access (DIVA) and those requiring extended therapy. The product combines extended catheter length, extended-dwell performance, multi-access blood control, and passive safety protection to support clinicians during challenging IV procedures.

The launch addresses several challenges associated with peripheral access when deeper vessels need to be reached. According to B. Braun, the catheter is designed around a familiar insertion platform that can be integrated into existing clinical workflows. Its combination of deep access capabilities and safety-focused features aims to provide clinicians with another option for patients who may otherwise require repeated IV attempts or escalation to more invasive vascular access devices.

Key Highlights of the Product Launch

• Extended Length: Designed to support deeper peripheral vascular access and maintain an appropriate length of catheter within the vein.
• Extended Dwell: Built on B. Braun’s Deep Access technology platform to support longer catheter dwell.
• Multi-access blood control: Designed to maintain blood control during insertion and each subsequent hub access.
• Passive Safety Protection: Fully automatic safety technology is designed to reduce the risk of needlestick injuries without adding additional workflow steps.
• Ultrasound-guided access: The product supports ultrasound-guided insertion, with an echogenic needle designed to improve visibility during placements.
• DIVA and extended therapy:  Specifically designed for difficult venous access and patients requiring longer-term peripheral IV therapy.

Impact on the Peripheral IV Catheter Market

The launch highlights the growing importance of specialized peripheral IV catheter technologies that address difficult access while improving safety and workflow efficiency. Healthcare providers increasingly require vascular access solutions that can support challenging patients without unnecessarily moving to more invasive devices.

B.Braun’s new catheter combined several functions within one platform, including longer access, blood control, and passive needlestick protection. This integrated approach can strengthen the value proposition of advanced peripheral IV catheters and encourage healthcare facilities to consider technology that supports both patient care and clinician safety.

The emphasis on extended dwell is also important for reducing repeated catheter replacements. By supporting deeper vessel access and longer catheter placements, the product is positioned to help address issues associated with short dwell times and repeated resticks.

Impact on Vascular Access Technology

The launch also demonstrates how ultrasound-guided vascular access is becoming an important area of medical-device innovation. The Introcan Safety 2 Deep Access IV Catheter is designed to help clinicians reach deeper vessels while maintaining a familiar insertion approach.

Its multi-access blood-control technology is another important feature. By maintaining blood control whenever the catheter hub is accessed, the device is designed to minimize blood exposure and support a cleaner and more efficient workflow. Passive safety technology further strengthens the product by helping protect clinicians from needlestick injuries without requiring additional procedural steps.

Strategic Significance for B. Braun

The product launch expands B. Braun’s ultrasound-guided deep access portfolio and strengthens its position in vascular alongside its Peripheral Advantage plus Programs, which combine product technology and education to support clinician competency, appropriate device selection, and advancement of vascular access care.

Future Opportunities

The launch creates opportunities for continued innovation in peripheral IV access, particularly for difficult-access and longer-stay patients. Future development in this segment may increasingly focus on extended dwell, ultrasound visibility, blood-exposure reduction, needlestick protection, and simpler clinical workflows.

With the Introcan Safety 2 Deep Access IV Catheter, B. Braun is strengthening the portfolio around these priorities while providing clinicians with an additional option for challenging peripheral vascular access procedures.